Halozyme Therapeutics, Inc. · NASDAQ:HALO
Halozyme Therapeutics, Inc. shareholders
As of Jun 30, 2026, 656 institutions reported holding Halozyme Therapeutics, Inc. Largest: BlackRock, Vanguard and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Halozyme Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 13.3M | +6,042 | Aug 7, 2026 | |
| Vanguard | 11.6M | +153K | Aug 13, 2026 | |
| State Street | 5.18M | +242K | Aug 7, 2026 | |
| Invesco | 3.18M | −834K | Aug 14, 2026 | |
| Morgan Stanley | 2.83M | +270K | Aug 13, 2026 | |
| Boston Partners | 2.77M | +89,885 | Aug 4, 2026 | |
| Bank of America | 2.74M | −173K | Aug 14, 2026 | |
| Geode Capital | 2.52M | +14,165 | Aug 12, 2026 | |
| William Blair Investment Management, LLC | 2.51M | −14,925 | Aug 12, 2026 | |
| Snyder Capital Management L P | 2.4M | +73,024 | Aug 13, 2026 |